Skip to main content
Skip to Footer

The Journal of Neuropsychiatry and Clinical Neurosciences

  • Volume 25
  • Number 2
  • April 2013

Letters

Windows to the Brain

Publication date: 01 April 2013

Pages96–102

This installment of the Windows to the Brain series offers an overview of oxytocin's many and varied effects, sites of action in the brain, and stimuli that are implicated in its actions. These include response to infant behavior, such as laughing or ...

https://doi.org/10.1176/appi.neuropsych.13030061

Special Articles

Publication date: 01 April 2013

Pages103–110

The authors explain and detail the effects of the kinetic energy of blast shock waves on the CNS, specifically, the volumetric blood surge through the brain and large and small blood vessels and its neuropsychiatric effects. In addition to the physical ...

https://doi.org/10.1176/appi.neuropsych.12030058

Publication date: 01 April 2013

Pages111–114

Examination and comparison of the current DSM-IV-TR and the proposed revisions for the forthcoming DSM-5, with regard to neuropsychiatric aspects of critical illness, identified five important issues. These remain to be addressed in order to improve the ...

https://doi.org/10.1176/appi.neuropsych.12020028

Regular Articles

Publication date: 01 April 2013

Pages115–119

The author collected clinical data on college athletes diagnosed with concussion between 1998 and 2011, looking at symptom duration, self-report of clinical, mood, and cognitive status, and time until return-to-play and resumption of usual activities. ...

https://doi.org/10.1176/appi.neuropsych.11120374

Publication date: 01 April 2013

Pages120–125

Recent reports highlighting serious adverse effects of antipsychotic medication in behavioral and psychological symptoms of dementia (BPSD) has led to calls for research on alternative agents. The authors describe the use of low-dose gabapentin to treat ...

https://doi.org/10.1176/appi.neuropsych.12050115

Publication date: 01 April 2013

Pages126–133

High rostral anterior cingulate cortex (rACC) activity has been shown to predict antidepressant treatment response; however, it is unclear whether this is a fixed versus variable marker of responsiveness. The authors measured rACC theta current density in ...

https://doi.org/10.1176/appi.neuropsych.11110330

Publication date: 01 April 2013

Pages134–140

The authors explored cross-sectional associations between MRI parameters (lesion metrics, brain volumes, magnetization transfer ratio histograms, and metabolite concentrations) and cognition in 61 patients who experienced clinically-isolated syndromes (...

https://doi.org/10.1176/appi.neuropsych.11090218

Publication date: 01 April 2013

Pages141–149

The aim of this study was to investigate the clinical, neuropsychological, and self-awareness correlates of impulse-control disorder (ICD) in a group of 17 Parkinson’s disease (PD) subjects with an active ICD and a comparison group of 17 PD subjects ...

https://doi.org/10.1176/appi.neuropsych.12030076

Clinical And Research Reports

Publication date: 01 April 2013

Pages150–152

Cobalamin (Vitamin B12) has been implicated in the pathogenesis of various neuropsychiatric disorders. A review of 19 patients (14 vegetarians) with demonstrable vitamin B12 deficiency showed varied psychiatric symptomatology, with the majority not having ...

https://doi.org/10.1176/appi.neuropsych.12060144

Clinical and Research Reports

Publication date: 01 April 2013

Pages153–156

Three elderly patients experienced musical hallucinations (MH) in the context of hearing loss. In at least two of the cases, the onset was sudden. All three patients had pontine T2/FLAIR hyperintense foci on MR scan after the onset of the MH.

https://doi.org/10.1176/appi.neuropsych.12050131

Clinical And Research Reports

Publication date: 01 April 2013

Pages157–160

The authors studied the efficacy and safety of combined venlafaxine and quetiapine treatment for treatment-resistant depression (TRD) by dividing 95 TRD patients into two treatment groups: a combined venlafaxine (225 mg/day) and quetiapine (400 mg/day) ...

https://doi.org/10.1176/appi.neuropsych.12070171

Departments

Errata

Past Issues

View Issues Archive
No.4
View Issue
1 Oct 2024

Vol. 36 | No. 4

No.3
View Issue
1 Jul 2024

Vol. 36 | No. 3

No.2
View Issue
1 Apr 2024

Vol. 36 | No. 2

No.1
View Issue
1 Jan 2024

Vol. 36 | No. 1